Skip to Content

CN

P0311

Protein Kinase inhibitors: heterocyclic aromatics

~95% (HPLC)

Sign Into View Organizational & Contract Pricing

Select a Size

Key Documents

View All Documentation

Technical Service

Need help? Our team of experienced scientists is here for you.

Technical Service

Need help? Our team of experienced scientists is here for you.

Assay

~95% (HPLC)

storage temp.

−20°C

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Biology of Actinomycetes.

Kase, H.

Proc. 7th Int. Symp. Biol of Actinomycetes, 159- 159 (1988)

Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.

Kayode K Ojo et al.

Antimicrobial agents and chemotherapy, 52(10), 3710-3717 (2008-07-23)

Development of a safe, effective, and inexpensive therapy for African trypanosomiasis is an urgent priority. In this study, we evaluated the validity of Trypanosoma brucei glycogen synthase kinase 3 (GSK-3) as a potential drug target. Interference with the RNA of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service